95 related articles for article (PubMed ID: 22920166)
1. Comparision of histological types of primary and subsequent relapsing basal cell carcinomas of the skin.
Bartos V; Adamicova K; Kullova M; Pec M
Klin Onkol; 2012; 25(4):262-6. PubMed ID: 22920166
[TBL] [Abstract][Full Text] [Related]
2. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
[TBL] [Abstract][Full Text] [Related]
3. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
Anthouli-Anagnostopoulou F; Hatziolou E
Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
[TBL] [Abstract][Full Text] [Related]
4. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.
Boulinguez S; Grison-Tabone C; Lamant L; Valmary S; Viraben R; Bonnetblanc JM; Bédane C
Br J Dermatol; 2004 Sep; 151(3):623-6. PubMed ID: 15377349
[TBL] [Abstract][Full Text] [Related]
5. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
6. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
8. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
9. Do basal cell carcinomas recur after complete conventional surgical excision?
Griffiths RW; Suvarna SK; Stone J
Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
[TBL] [Abstract][Full Text] [Related]
10. Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.
Bierhoff E; Appel K; Appel T; Buettner R; Wardelmann E
Anticancer Res; 2003; 23(3B):2697-700. PubMed ID: 12894560
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
12. Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma.
Roozeboom MH; Mosterd K; Winnepenninckx VJ; Nelemans PJ; Kelleners-Smeets NW
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):894-8. PubMed ID: 22691131
[TBL] [Abstract][Full Text] [Related]
13. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
14. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
[TBL] [Abstract][Full Text] [Related]
15. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 256 cases of basal cell carcinoma after either one-step or two-step surgery in a Japanese institution.
Goto M; Kai Y; Arakawa S; Oishi M; Ishikawa K; Anzai S; Hatano Y; Okamoto O; Katagiri K; Fujiwara S; Shimizu F; Kato A; Shibuya H; Eshima N; Terashi H
J Dermatol; 2012 Jan; 39(1):68-71. PubMed ID: 21951151
[TBL] [Abstract][Full Text] [Related]
17. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
Mitcov M; Scrivener Y; Cribier B
Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
[TBL] [Abstract][Full Text] [Related]
18. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
20. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
